FBXW7 and non-small cell lung carcinoma: In vitro studies revealed that elevated FBXW7 expression promotes the ubiquitin-mediated degradation of Snai1, which inhibits the EMT process and the renewal capacity of CSCs and consequently restores the sensitivity of NSCLC cells to the above drugs (Xiao G. et al., 2018).